News Daily News In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report Michael O'Riordan January 27, 2022
News Daily News AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD Caitlin E. Cox December 28, 2021
News Conference News AHA 2021 Risk-Based EHR Alert Doesn’t Improve HF Care or Outcomes: REVEAL-HF Michael O'Riordan November 19, 2021
News Daily News Age Not the Only Explanation for Sex Gap in PCI Care, Outcomes Caitlin E. Cox November 03, 2021
News Features Four Pillars, Fast? Rapid Sequencing of HF Drugs Faces an Uphill Battle Shelley Wood October 08, 2021
News Conference News HFSA 2021 Digital App Improves HF Quality-of-Care Metrics: CONNECT-AF Michael O'Riordan September 14, 2021
News Conference News ESC 2021 New ESC HF Guidelines Showcase SGLT2 Inhibitors, Tafamidis, Vericiguat, and COAPT Shelley Wood August 28, 2021
News Daily News Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2 Michael O'Riordan August 26, 2021
News Daily News Retracted Over Fraud Concerns, Surgisphere ACE/ARB Study Still Gets Cited Michael O'Riordan August 03, 2021
News Daily News ARBs Preferable to ACE Inhibitors in Large Observational Hypertension Study Michael O'Riordan July 27, 2021
News Conference News TVT 2021 Optimizing Medical Therapy Before Clip Repair for MR? ‘This Is Hard’ Todd Neale July 27, 2021
News Daily News Studies Explore Post-MI Use of Beta-blockers, Mineralocorticoid Receptor Antagonists Todd Neale July 09, 2021
News Daily News OMT Boosts Survival in Revascularized Patients at 10 Years Michael O'Riordan June 29, 2021
News Opinion Off Script From the Dress Rehearsal to Closing Night: Lessons in Humility and Hope Ankur Kalra June 15, 2021
News Daily News Periprocedural MIs Associated With PCI Prognostically Relevant: ESC/EAPCI Michael O'Riordan June 10, 2021
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2021 Shelley Wood May 31, 2021
News Daily News Dapagliflozin US Cost-effectiveness Data Expose Barriers to HF Care Shelley Wood May 27, 2021